Advertisement

Using PET Scans to Direct Therapy Decisions in Advanced Hodgkin Lymphoma
Posted: 02/18/2022 | By: Justine Landin, PhD

Question 1 of 5

Which of the following statements is FALSE regarding a positron-emission tomography (PET)-driven de-escalation strategy after two cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone, or BEACOPP?

Choose 1

A
PET assessment provided similar overall survival compared with a nonmonitored treatment
B
Early toxicity was reduced with PET assessment compared to nonmonitored treatment
C
PET assessment predicted patients’ 5-year progression-free survival
D
Five-year overall survival was not affected by interim PET results

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage